Ipamorelin Reconstitution Protocol: Laboratory Preparation for Research Use
Ipamorelin Reconstitution Protocol: Laboratory Preparation for Research Use
Ipamorelin represents a pentapeptide growth hormone secretagogue that has gained significant attention in peptide research laboratories worldwide. This synthetic compound demonstrates selective binding affinity for growth hormone secretagogue receptors, making it an invaluable tool for investigating growth hormone release mechanisms and related physiological pathways. The lyophilised formulation ensures optimal stability during storage while maintaining peptide integrity for extended research periods.
Research applications encompass metabolic studies, cellular signaling pathway investigations, and receptor binding assays. The compound's selectivity profile makes it particularly suitable for comparative studies against other growth hormone releasing peptides, providing researchers with precise experimental control over growth hormone secretagogue receptor activation patterns.
Materials Required
Ipamorelin 5mg lyophilised vial (Element SARMs)
Bacteriostatic water for injection (0.9% benzyl alcohol)
Sterile water for injection (alternative solvent)
1mL sterile syringes with Luer-lock connection
27-30 gauge sterile needles
70% isopropyl alcohol swabs
Laminar flow hood or biosafety cabinet
Sterile glass vials for aliquot storage
Laboratory marker for labeling
Micropipettes and sterile tips (optional for precise volumes)
Pre-Reconstitution Preparation
Establish aseptic conditions within the designated laboratory workspace by thoroughly sanitizing all surfaces with 70% isopropyl alcohol. Activate the laminar flow hood and allow proper air circulation for a minimum of 15 minutes before commencing reconstitution procedures. Remove the lyophilised vial from refrigerated storage and allow equilibration to room temperature for approximately 10 minutes, preventing thermal shock during solvent addition.
Inspect the lyophilised material for uniform appearance and absence of discoloration. The peptide should appear as a white to off-white powder with minimal clumping. Calculate the required solvent volume based on desired final concentration using the formula: Volume (mL) = Total peptide mass (mg) ÷ Desired concentration (mg/mL).
Step-by-Step Reconstitution Protocol
Step 1: Don sterile gloves and position all materials within the laminar flow hood workspace. Remove the aluminum crimp cap and sanitize the rubber stopper surface with 70% isopropyl alcohol, allowing complete evaporation before needle insertion.
Step 2: Draw the calculated volume of bacteriostatic water into a sterile syringe using a fresh needle. Remove any air bubbles by gently tapping the syringe and expressing excess air through the needle tip.
Step 3: Insert the needle through the rubber stopper at a 45-degree angle, avoiding direct contact with the lyophilised material. Direct the solvent flow against the vial wall rather than directly onto the peptide powder to prevent foaming and potential peptide degradation.
Step 4: Add the solvent slowly in a controlled manner, allowing the liquid to flow down the vial wall. This technique minimizes mechanical stress on the peptide structure and ensures gentle dissolution.
Step 5: Remove the syringe and needle, then gently rotate the vial between your palms to facilitate complete dissolution. Avoid vigorous shaking or vortexing, which may denature the peptide structure. Complete dissolution typically occurs within 2-3 minutes.
Step 6: Inspect the reconstituted solution for clarity and absence of particulate matter. The final solution should appear clear and colorless without visible precipitation or cloudiness.
Resulting Concentration Options
1.0 mL
5.0 mg/mL
High-concentration stock solution
2.0 mL
2.5 mg/mL
Standard working concentration
5.0 mL
1.0 mg/mL
Dilute research applications
Storage Conditions
Store reconstituted Ipamorelin solutions at 2-8°C in sterile glass vials to maintain peptide stability and prevent bacterial contamination. Solutions prepared with bacteriostatic water demonstrate stability for up to 28 days under proper refrigeration conditions. For extended storage periods, prepare small aliquots and store at -20°C, avoiding repeated freeze-thaw cycles that may compromise peptide integrity.
Label all containers with reconstitution date, concentration, and batch information for proper laboratory documentation and traceability.
Research Application Notes
Element SARMs Ipamorelin demonstrates excellent solubility characteristics in aqueous solutions, facilitating diverse research methodologies including cell culture studies, receptor binding assays, and biochemical analysis protocols. The reconstituted peptide maintains biological activity when stored under appropriate conditions, ensuring reliable experimental reproducibility across multiple research sessions.
All content is intended for in vitro laboratory research purposes only. Not for human or animal consumption. Not intended to diagnose, treat, cure, or prevent any condition.
Hexarelin
TB-500
Epithalon
Ipamorelin
Tirzepatide
CJC-1295 DAC
PT-141
Semaglutide
Selank
BPC-157
Sermorelin
Melanotan 2
IGF LR3
Tesamorelin
AICAR
IGF-DES
GHRP 2
Albuterol
Tamoxifen
Letrozole
Clomiphene
Tadalafil
Clenbuterol
Anastrozole
Finasteride
Exemestane
Sildenafil
Yohimbine
Bacteriostatic Water Recent Posts Melanotan 2 (MT2): Mechanism, Research, and Safety Considerations Ipamorelin: The Selective GHRP, Explained Tesamorelin: The GHRH Analog Studied for Visceral Fat Sermorelin: The Original GHRH Analog, Explained CJC-1295: How the GHRH Analog Works, and What Research Shows
Already a customer? Sign In
Create Account
All products on this site are for Research, Development use only. Products are Not for Human consumption of any kind. The statements made within this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure or prevent any disease.
ElementSarms is a chemical supplier. ElementSarms is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic act. ElementSarms is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic act.
Sarms
Stacks
Research Liquids
Albuterol 5MG/ML | 30ML with dropper
Anastrozole 1.5MG/ML | 30ML with dropper
Clomiphene 50MG/ML | 30ML with dropper
Finasteride 5MG/ML | 30ML with dropper
Letrozole 3.5 MG/ML | 30ML with dropper
LiquiCia 30MG/ML | 30ML with dropper
LiquiCia T50 50MG/ML | 30ML with dropper
LiquiClen 200MCG/ML | 30ML with dropper
Liquistane / Exemestane 25MG/ML | 30ML with dropper
LiquiTamo 20MG/ML | 30ML with dropper
LiquiVia 25MG/ML | 30 ML with dropper
T3 LIOTHYRONINE 200MCG/ML | 30ML with dropper
Toremifene Citrate 60MG/ML | 30ML with dropper
Yohimbine HCL 10MG/ML | 30ML with dropper
Research Peptides
Aicar 50MG
BPC-157 + TB-500 Blend 2mg ea/ 4MG
BPC-157 5MG
CJC-1295 + DAC 2MG
CJC-1295 | No DAC 2MG
Epithalon 10MG
Frag Premium 176-191 5MG
GHK-CU Copper Peptide 50MG
GHRP-2 5MG
GHRP-6 5MG
Hexarelin 5MG
IGF-1 DES 1MG
IGF-1 LR3 1MG
Ipamorelin 5MG
Melanotan 2 10MG
NAD+ 500MG
PT-141 / Bremelanotide 10MG
GLP-1/GIP/GCG (RT)
Selank 5MG
GLP1 (SM)
Sermorelin 5MG
TB-500 5MG
GIP/GLP-1 (TZ)
PDE5 Inhibitors
GLP-1
Diluents
Bacteriostatic Water 10ML